<DOC>
	<DOCNO>NCT01332500</DOCNO>
	<brief_summary>The purpose retrospective claim database study compare change migraine-related prescription ( i.e . NSAIDs , Opioids , Ergots ) utilization among migraine suffers follow initiation Treximet ™ ( sumatriptan/naproxen ) compare subject initiate treatment orally available triptans . The study use validate migraine-related prescription utilization pattern predict Treximet ™ Budget Impact Model . The SourceLx dataset family Wolters Kluwer database use analysis . The database contain 30 % prescription claim fill United States ( US ) , approximately 160 million patient life . The data broad representative coverage geographic payment level .</brief_summary>
	<brief_title>Treximet ™ Pharmacy Budget Impact Model Database Validation Study</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>At least one prescription claim either Treximet ™ orally administer triptan least 18 year age index Rx date least one prescription claim medication pre postindex period ( proxy continuous enrollment ) Subjects receive nasal sumatriptan time Subjects 65 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Triptans</keyword>
	<keyword>Migraine</keyword>
</DOC>